Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.

O'Hara GA, Duncan CJ, Ewer KJ, Collins KA, Elias SC, Halstead FD, Goodman AL, Edwards NJ, Reyes-Sandoval A, Bird P, Rowland R, Sheehy SH, Poulton ID, Hutchings C, Todryk S, Andrews L, Folgori A, Berrie E, Moyle S, Nicosia A, Colloca S, Cortese R, Siani L, Lawrie AM, Gilbert SC, Hill AV.

J Infect Dis. 2012 Mar 1;205(5):772-81. doi: 10.1093/infdis/jir850. Epub 2012 Jan 24.

PMID:
22275401
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine.

Porter DW, Thompson FM, Berthoud TK, Hutchings CL, Andrews L, Biswas S, Poulton I, Prieur E, Correa S, Rowland R, Lang T, Williams J, Gilbert SC, Sinden RE, Todryk S, Hill AV.

Vaccine. 2011 Oct 6;29(43):7514-22. doi: 10.1016/j.vaccine.2011.03.083. Epub 2011 Apr 16.

PMID:
21501642
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming.

Todryk SM, Pathan AA, Keating S, Porter DW, Berthoud T, Thompson F, Klenerman P, Hill AV.

Immunology. 2009 Sep;128(1):83-91. doi: 10.1111/j.1365-2567.2009.03073.x. Erratum in: Immunology. 2011 Apr;132(4):589.

PMID:
19689738
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines.

Berthoud TK, Dunachie SJ, Todryk S, Hill AV, Fletcher HA.

J Immunol Methods. 2009 Jan 1;340(1):33-41. doi: 10.1016/j.jim.2008.09.021. Epub 2008 Oct 24. Erratum in: J Immunol Methods. 2011 May 31;368(1-2):84.

PMID:
18952093
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.

Todryk SM, Bejon P, Mwangi T, Plebanski M, Urban B, Marsh K, Hill AV, Flanagan KL.

PLoS One. 2008 Apr 30;3(4):e2027. doi: 10.1371/journal.pone.0002027. Erratum in: PLoS One. 2011;6(2). doi: 10.1371/annotation/23d1eb6a-45de-4181-a6dd-eff9b08d2669.

PMID:
18446217
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial.

Thompson FM, Porter DW, Okitsu SL, Westerfeld N, Vogel D, Todryk S, Poulton I, Correa S, Hutchings C, Berthoud T, Dunachie S, Andrews L, Williams JL, Sinden R, Gilbert SC, Pluschke G, Zurbriggen R, Hill AV.

PLoS One. 2008 Jan 30;3(1):e1493. doi: 10.1371/journal.pone.0001493. Erratum in: PLoS One. 2011;6(2). doi: 10.1371/annotation/419b2f36-d46f-4f8a-8ffb-7fd2bfb33aa6.

PMID:
18231580
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum.

Bejon P, Mwacharo J, Kai O, Todryk S, Keating S, Lowe B, Lang T, Mwangi TW, Gilbert SC, Peshu N, Marsh K, Hill AV.

J Immunol. 2007 Sep 15;179(6):4193-201.

PMID:
17785859
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Viral vector vaccines make memory T cells against malaria.

Reyes-Sandoval A, Harty JT, Todryk SM.

Immunology. 2007 Jun;121(2):158-65. Review.

PMID:
17462077
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.

Bejon P, Mwacharo J, Kai O, Mwangi T, Milligan P, Todryk S, Keating S, Lang T, Lowe B, Gikonyo C, Molyneux C, Fegan G, Gilbert SC, Peshu N, Marsh K, Hill AV.

PLoS Clin Trials. 2006 Oct 20;1(6):e29.

PMID:
17053830
[PubMed]
Free PMC Article
10.

Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.

Walther M, Thompson FM, Dunachie S, Keating S, Todryk S, Berthoud T, Andrews L, Andersen RF, Moore A, Gilbert SC, Poulton I, Dubovsky F, Tierney E, Correa S, Huntcooke A, Butcher G, Williams J, Sinden RE, Hill AV.

Infect Immun. 2006 May;74(5):2706-16.

PMID:
16622207
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Malaria pigment paralyzes dendritic cells.

Urban BC, Todryk S.

J Biol. 2006;5(2):4. Epub 2006 Apr 12. Review.

PMID:
16620370
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A novel method to identify and characterise peptide mimotopes of heat shock protein 70-associated antigens.

Arnaiz B, Madrigal-Estebas L, Todryk S, James TC, Doherty DG, Bond U.

J Immune Based Ther Vaccines. 2006 Apr 8;4:2.

PMID:
16603084
[PubMed]
Free PMC Article
13.

Building better T-cell-inducing malaria vaccines.

Todryk SM, Walther M.

Immunology. 2005 Jun;115(2):163-9. Review.

PMID:
15885121
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo.

Flynn MA, Casey DG, Todryk SM, Mahon BP.

J Inflamm (Lond). 2004 Oct 1;1(1):4.

PMID:
15813981
[PubMed - as supplied by publisher]
Free PMC Article
15.

Heat shock protein derived from a non-autologous tumour can be used as an anti-tumour vaccine.

Casey DG, Lysaght J, James T, Bateman A, Melcher AA, Todryk SM.

Immunology. 2003 Sep;110(1):105-11.

PMID:
12941147
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Facets of heat shock protein 70 show immunotherapeutic potential.

Todryk SM, Gough MJ, Pockley AG.

Immunology. 2003 Sep;110(1):1-9. Review.

PMID:
12941135
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A sense of tumour for the immune system.

Todryk S.

Immunology. 2002 Sep;107(1):1-4. Review. No abstract available.

PMID:
12225356
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Efficacy of cytokine gene transfection may differ for autologous and allogeneic tumour cell vaccines.

Todryk SM, Birchall LJ, Erlich R, Halanek N, Orleans-Lindsay JK, Dalgleish AG.

Immunology. 2001 Feb;102(2):190-8.

PMID:
11260324
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Heat shock proteins refine the danger theory.

Todryk SM, Melcher AA, Dalgleish AG, Vile RG.

Immunology. 2000 Mar;99(3):334-7. No abstract available.

PMID:
10712661
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Can immunotherapy by gene transfer tip the balance against colorectal cancer?

Todryk SM, Chong H, Vile RG, Pandha H, Lemoine NR.

Gut. 1998 Oct;43(4):445-9.

PMID:
9824562
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk